- Foreword
- Contributors
- 1 Primer on Depression
- 2 Neurobiology
- 3 Genetic Risk Factors of Depression
- 4 Environmental and Social Risk Factors in Depression
- 5 Biomarkers Predicting Antidepressant Treatment Response
- 6 Anxiety Disorders
- 7 Bipolar Disorder
- 8 Primer on Depression
- 9 General Medical Conditions
- 10 General Medical Conditions
- 11 First-Line and Combination Therapeutics for Major Depressive Disorder
- 12 Primer on Depression
- 13 Rapid-Acting Antidepressants
- 14 Management of Side Effects of Antidepressant Medications
- 15 Pharmacological Strategies for Targeting Residual Symptoms in Depression
- 16 Cognitive Behavior Therapy
- 17 Behavioral Activation for Depression
- 18 Psychodynamic and Supportive Psychotherapy
- 19 Neuromodulation for Depression
- 20 Exercise as a Treatment for Depression
- 21 Therapeutic Mindfulness and Depression
- 22 Probiotics and Nutraceuticals
- 23 Chronobiological Treatments
- 24 Child and Adolescent Depression
- 25 Depression in Older Adults
- 26 Postpartum Depression
- 27 Depression Following Mild Traumatic Brain Injury
- 28 Primer on Depression
- 29 Precision Medicine for the Treatment of Depression
- Index
(p. 418) Depression in Older Adults
- Chapter:
- (p. 418) Depression in Older Adults
- Author(s):
Hanadi Ajam Oughli
, Jordan F. Karp
, and Eric J. Lenze
- DOI:
- 10.1093/med/9780190929565.003.0025
Late-life depression (LLD) is relatively common in older adults. It is associated with deleterious health outcomes, exacerbates frailty and functional decline, and contributes to all-cause mortality. LLD tends to have a chronic course, with frequent recurrences and relapses. This chapter reviews the clinical presentation, assessment, and etiologies of LLD. The chapter also focuses on therapeutic targets of LLD, which include pharmacotherapy, neurostimulation, and psychosocial treatment. An antidepressant treatment algorithm based on a summary of current data, clinical evidence and expert opinion is included to help guide physicians. Additionally, psychotropic medications with novel mechanisms of action are discussed with some directions for further research.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Foreword
- Contributors
- 1 Primer on Depression
- 2 Neurobiology
- 3 Genetic Risk Factors of Depression
- 4 Environmental and Social Risk Factors in Depression
- 5 Biomarkers Predicting Antidepressant Treatment Response
- 6 Anxiety Disorders
- 7 Bipolar Disorder
- 8 Primer on Depression
- 9 General Medical Conditions
- 10 General Medical Conditions
- 11 First-Line and Combination Therapeutics for Major Depressive Disorder
- 12 Primer on Depression
- 13 Rapid-Acting Antidepressants
- 14 Management of Side Effects of Antidepressant Medications
- 15 Pharmacological Strategies for Targeting Residual Symptoms in Depression
- 16 Cognitive Behavior Therapy
- 17 Behavioral Activation for Depression
- 18 Psychodynamic and Supportive Psychotherapy
- 19 Neuromodulation for Depression
- 20 Exercise as a Treatment for Depression
- 21 Therapeutic Mindfulness and Depression
- 22 Probiotics and Nutraceuticals
- 23 Chronobiological Treatments
- 24 Child and Adolescent Depression
- 25 Depression in Older Adults
- 26 Postpartum Depression
- 27 Depression Following Mild Traumatic Brain Injury
- 28 Primer on Depression
- 29 Precision Medicine for the Treatment of Depression
- Index